tiprankstipranks
Nkarta Announces Pricing of $240 Million Underwritten Offering
PremiumPress ReleasesNkarta Announces Pricing of $240 Million Underwritten Offering
26d ago
Nkarta’s NKX019 Shows Potential in Lymphoma Treatment
PremiumCompany Announcements
Nkarta’s NKX019 Shows Potential in Lymphoma Treatment
26d ago
Nkarta trading resumes
PremiumThe Fly
Nkarta trading resumes
29d ago
Nkarta reports Q4 EPS (57c), consensus (59c)
PremiumThe FlyNkarta reports Q4 EPS (57c), consensus (59c)
29d ago
Nkarta Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Highlights
PremiumPress Releases
Nkarta Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Highlights
29d ago
Nkarta options imply 10.4% move in share price post-earnings
PremiumThe Fly
Nkarta options imply 10.4% move in share price post-earnings
29d ago
Nkarta presents NKX101 clinical data at 2023 ASH Annual Meeting
PremiumThe FlyNkarta presents NKX101 clinical data at 2023 ASH Annual Meeting
4M ago
Nkarta Presents NKX101 Clinical Data at the 2023 American Society of Hematology Annual Meeting & Exposition
PremiumPress Releases
Nkarta Presents NKX101 Clinical Data at the 2023 American Society of Hematology Annual Meeting & Exposition
4M ago
Nkarta price target lowered to $9 from $15 at Mizuho
PremiumThe Fly
Nkarta price target lowered to $9 from $15 at Mizuho
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100